 Connection
Thomas Anchordoquy to Plasmids
This is a "connection" page, showing publications Thomas Anchordoquy has written about Plasmids.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.962 |
|
|
|
-
Kullberg M, McCarthy R, Anchordoquy TJ. Gene delivery to Her-2+ breast cancer cells using a two-component delivery system to achieve specificity. Nanomedicine. 2014 Aug; 10(6):1253-62.
Score: 0.380
-
Betker J, Smyth T, Wang W, Anchordoquy TJ. Application of a ultra performance liquid chromatography method in the determination of DNA quality and stability. J Pharm Sci. 2012 Mar; 101(3):987-97.
Score: 0.324
-
Lengsfeld CS, Anchordoquy TJ. Shear-induced degradation of plasmid DNA. J Pharm Sci. 2002 Jul; 91(7):1581-9.
Score: 0.169
-
Betker JL, Anchordoquy TJ. The Effect of Repeat Administration of Lipoplexes on Gene Delivery, Biodistribution, and Cytokine Response in Immunocompetent Tumor-Bearing Mice. J Pharm Sci. 2022 07; 111(7):1926-1936.
Score: 0.163
-
Anchordoquy TJ, Koe GS. Physical stability of nonviral plasmid-based therapeutics. J Pharm Sci. 2000 Mar; 89(3):289-96.
Score: 0.144
-
Betker JL, Jones D, Childs CR, Helm KM, Terrell K, Nagel MA, Anchordoquy TJ. Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery. J Control Release. 2018 09 28; 286:85-93.
Score: 0.128
-
Betker JL, Anchordoquy TJ. Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery. Drug Deliv Transl Res. 2017 02; 7(1):162-167.
Score: 0.116
-
Betker JL, Anchordoquy TJ. Relating toxicity to transfection: using sphingosine to maintain prolonged expression in vitro. Mol Pharm. 2015 Jan 05; 12(1):264-73.
Score: 0.100
-
Xu L, Betker J, Yin H, Anchordoquy TJ. Ligands located within a cholesterol domain enhance gene delivery to the target tissue. J Control Release. 2012 May 30; 160(1):57-63.
Score: 0.083
-
Lengsfeld CS, Munson L, Lentz YK, Anchordoquy TJ. DNA hydrodynamic degradation controlled by Kolomogorov length scales in pipe flow. J Pharm Sci. 2011 Aug; 100(8):3088-3095.
Score: 0.078
-
Xu L, Anchordoquy T. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci. 2011 Jan; 100(1):38-52.
Score: 0.076
-
Zhang Y, Bradshaw-Pierce EL, Delille A, Gustafson DL, Anchordoquy TJ. In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. J Pharm Sci. 2008 Jan; 97(1):237-50.
Score: 0.062
-
Molina MC, Allison SD, Anchordoquy TJ. Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: insight from other structural indicators. J Pharm Sci. 2001 Oct; 90(10):1445-55.
Score: 0.040
-
Choosakoonkriang S, Wiethoff CM, Anchordoquy TJ, Koe GS, Smith JG, Middaugh CR. Infrared spectroscopic characterization of the interaction of cationic lipids with plasmid DNA. J Biol Chem. 2001 Mar 16; 276(11):8037-43.
Score: 0.038
-
Allison SD, Molina MC, Anchordoquy TJ. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim Biophys Acta. 2000 Sep 29; 1468(1-2):127-38.
Score: 0.037
-
Lentz YK, Anchordoquy TJ, Lengsfeld CS. DNA acts as a nucleation site for transient cavitation in the ultrasonic nebulizer. J Pharm Sci. 2006 Mar; 95(3):607-19.
Score: 0.014
-
Lentz YK, Anchordoquy TJ, Lengsfeld CS. Rationale for the selection of an aerosol delivery system for gene delivery. J Aerosol Med. 2006; 19(3):372-84.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|